Workflow
天康生物:8月1日召开董事会会议

Group 1 - The company TianKang Biological (SZ 002100) announced that its 26th temporary board meeting of the 8th session was held on August 1, 2025, via communication voting [1] - The meeting reviewed documents including the proposal for the estimated financing guarantee amount for the year 2025 [1] - For the year 2024, the company's revenue composition is as follows: pig farming accounts for 35.84%, feed accounts for 31.12%, corn storage industry accounts for 12.48%, agricultural product processing accounts for 9.73%, and veterinary drugs account for 5.81% [1]